Clinical Trial Update: Long Term Evaluation of Sevelamer HCl vs. Calcium-based Phosphate Binder in the Treatment of Hyperphosphatemia in Hemodialysis Patients [Phase 4]

View source ↗

Summary

Phase 4 long-term evaluation comparing sevelamer hydrochloride with a calcium-based phosphate binder in hyperphosphatemia among hemodialysis patients has comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• End-stage Renal Disease
• Hyperphosphatemia

Drugs mentioned

• Calcium-based phosphate binder (calcium-based phosphate binder)
• Renagel (sevelamer)

Snippet

Sponsor: Chugai Pharma Taiwan | Conditions: Hemodialysis, Hyperphosphatemia | Phase 4 | Status: COMPLETED